Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
2,050
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Efficient treatment of Parkinson’s disease using ultrasonography-guided rhFGF20 proteoliposomes

Jianlou NiuSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Junjun XieSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Kaiwen GuoSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Xiaomin ZhangSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Feng XiaSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Xinyu ZhaoSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Lintao SongSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Deli ZhugeSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Xiaokun LiSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information
,
Yingzheng ZhaoSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaCorrespondence[email protected]
View further author information
&
Zhifeng HuangSchool of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, Zhejiang, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1560-1569 | Received 17 Apr 2018, Accepted 28 May 2018, Published online: 25 Jul 2018

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yun-Xiao Zhong, Jin-Chi Liao, Xv Liu, Hao Tian, Li-Ren Deng & Ling Long. (2023) Low intensity focused ultrasound: a new prospect for the treatment of Parkinson’s disease. Annals of Medicine 55:2.
Read now

Articles from other publishers (23)

Luping Qiu, Zhining Zhu, Jing Liang, Xiaohui Qiao, Huning Xu, Huijing Xiang, Hong Ding & Yu Chen. (2024) Micro/nanoparticle-enabled ultrasound therapy of brain diseases. Coordination Chemistry Reviews 500, pages 215531.
Crossref
Mohammad Amin Rajizadeh, Sina Motamedy, Yousof Mir, Faezeh Akhgarandouz, Mohammad Hadi Nematollahi & Akram Nezhadi. (2023) A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms. Journal of Drug Delivery Science and Technology 89, pages 105011.
Crossref
Katherine Muksuris, David M. Scarisbrick, James J. MahoneyIIIIII & Mariya V. Cherkasova. (2023) Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models. Journal of Clinical Medicine 12:17, pages 5448.
Crossref
Aneta Michna, Agata Pomorska & Ozlem Ozcan. (2023) Biocompatible Macroion/Growth Factor Assemblies for Medical Applications. Biomolecules 13:4, pages 609.
Crossref
Naumih M. Noah, Betty N. Mbatia & Calvin A. Omolo. 2023. Advanced Nanoformulations. Advanced Nanoformulations 685 717 .
Nilima Prakash. (2022) Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration. Frontiers in Molecular Neuroscience 15.
Crossref
Guowang Cheng, Yujing Liu, Rui Ma, Guopan Cheng, Yucheng Guan, Xiaojia Chen, Zhenfeng Wu & Tongkai Chen. (2022) Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials. Nano-Micro Letters 14:1.
Crossref
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, Md. Harun-Or-Rashid, Tanmay Kumar Ray, Md. Saidur Rahaman, Mahfuzul Islam, Fazilatunnesa Anika, Md. Kawser Hosain, Farjana Islam Aovi, Hassan A. Hemeg, Abdur Rauf & Polrat Wilairatana. (2022) Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance. Biomedicine & Pharmacotherapy 153, pages 113305.
Crossref
Zhewei Gu, Zhiyu Yin, Pengbo Song, Ying Wu, Ying He, Maoshu Zhu, Zhengxin Wu, Sicheng Zhao, Hongri Huang, Huihuang Wang, Cailing Tong & Zhongquan Qi. (2022) Safety and biodistribution of exosomes derived from human induced pluripotent stem cells. Frontiers in Bioengineering and Biotechnology 10.
Crossref
David M. Ornitz & Nobuyuki Itoh. (2022) New developments in the biology of fibroblast growth factors. WIREs Mechanisms of Disease 14:4.
Crossref
Keyang Chen, Zhiheng Rao, Siyang Dong, Yajing Chen, Xulan Wang, Yongde Luo, Fanghua Gong & Xiaokun Li. (2022) Roles of the fibroblast growth factor signal transduction system in tissue injury repair. Burns & Trauma 10.
Crossref
Sarah Jarrin, Abrar Hakami, Ben Newland & Eilís Dowd. (2021) Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery Systems. Journal of Parkinson's Disease 11:s2, pages S229-S236.
Crossref
Yiqiu Liu, Junyu Deng, Ye Liu, Wei Li & Xuqiang Nie. (2021) FGF, Mechanism of Action, Role in Parkinson’s Disease, and Therapeutics. Frontiers in Pharmacology 12.
Crossref
Jun Chen, Xue Wang, Jian Hu, Jingting Du, Confidence Dordoe, Qiulin Zhou, Wenting Huang, Ruili Guo, Fanyi Han, Kaiming Guo, Shasha Ye, Li Lin & Xiaokun Li. (2021) FGF20 Protected Against BBB Disruption After Traumatic Brain Injury by Upregulating Junction Protein Expression and Inhibiting the Inflammatory Response. Frontiers in Pharmacology 11.
Crossref
Clive Ballard, Dag Aarsland, Jeffrey Cummings, John O’Brien, Roger Mills, Jose Luis Molinuevo, Tormod Fladby, Gareth Williams, Pat Doherty, Anne Corbett & Janet Sultana. (2020) Drug repositioning and repurposing for Alzheimer disease. Nature Reviews Neurology 16:12, pages 661-673.
Crossref
Kankai Wang, Xiaohong Zhu, Enxing Yu, Priyanka Desai, Hao Wang, Chun-li Zhang, Qichuan Zhuge, Jianjing Yang & Jiangnan Hu. (2020) Therapeutic Nanomaterials for Neurological Diseases and Cancer Therapy. Journal of Nanomaterials 2020, pages 1-18.
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases. Journal of the Taiwan Institute of Chemical Engineers 114, pages 12-23.
Crossref
Hong-Xu Chen, Fu-Chao Liang, Ping Gu, Bian-Ling Xu, Hong-Jun Xu, Wen-Ting Wang, Jia-Yang Hou, Dong-Xiao Xie, Xi-Qing Chai & Sheng-Jun An. (2020) Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. Cell Death & Disease 11:4.
Crossref
M.I. Teixeira, C.M. Lopes, M.H. Amaral & P.C. Costa. (2020) Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. European Journal of Pharmaceutics and Biopharmaceutics 149, pages 192-217.
Crossref
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics 75 88 .
Edward J. R. Fletcher, Aran D. Jamieson, Gareth Williams, Patrick Doherty & Susan Duty. (2019) Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats. Scientific Reports 9:1.
Crossref
Eun Jung Lee, Anton Fomenko & Andres M. Lozano. (2019) Magnetic Resonance-Guided Focused Ultrasound : Current Status and Future Perspectives in Thermal Ablation and Blood-Brain Barrier Opening. Journal of Korean Neurosurgical Society 62:1, pages 10-26.
Crossref
Pablo Vicente Torres-Ortega, Iván Martínez-Valbuena, Gloria Martí-Andrés, Amira Sayed Hanafy, María Rosario Luquin, Elisa Garbayo & María José Blanco-Prieto. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases 177 208 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.